The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 27, 2015

Filed:

May. 29, 2007
Applicants:

Antonio Gualberto, East Greenwich, RI (US);

Maria Luisa Paccagnella, Noank, CT (US);

Carrie L. Melvin, Ledyard, CT (US);

Madeline I. Repollet, Fort Washington, PA (US);

David Chianese, Ardmore, PA (US);

Mark Carle Connelly, Doylestown, PA (US);

Leonardus Wendelinus Mathias Marie Terstappen, Huntingdon Valley, PA (US);

Inventors:

Antonio Gualberto, East Greenwich, RI (US);

Maria Luisa Paccagnella, Noank, CT (US);

Carrie L. Melvin, Ledyard, CT (US);

Madeline I. Repollet, Fort Washington, PA (US);

David Chianese, Ardmore, PA (US);

Mark Carle Connelly, Doylestown, PA (US);

Leonardus Wendelinus Mathias Marie Terstappen, Huntingdon Valley, PA (US);

Assignees:

Veridex LLC, New York, NY (US);

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); G01N 33/50 (2006.01); G01N 30/02 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5064 (2013.01); G01N 33/5023 (2013.01); G01N 33/574 (2013.01); G01N 30/02 (2013.01); G01N 2333/4745 (2013.01); G01N 2800/52 (2013.01);
Abstract

Methods for the detection, enumeration and analysis of circulating tumor cells expressing insulin-like growth factor-1 receptors (IGF-1R) are disclosed. These methods are useful for cancer screening and staging, development of treatment regimens, and for monitoring for treatment responses, cancer recurrence or the like. Test kits that facilitate the detection, enumeration and analysis of such circulating tumor cells are also provided.


Find Patent Forward Citations

Loading…